We are on a mission to change the way in which healthcare is provided by giving researchers the ability to closely examine the continuum from health to disease. Click on one of the therapeutic category icons below to learn how our revolutionary technology is helping researchers advance the science of precision health.
Our CEO and Executive Chairman, Kevin Hrusovsky, discusses the future of Quanterix and how we’re enabling transformation to precision health in this compelling webcast. Listen as he discusses how we’re shifting treatment centric “sick care” to prevention focused healthcare through our digital and non-invasive technology, Simoa, to continue fueling our impressive momentum and rigorous growth strategy in 2017.
Quanterix' proprietary Simoa™ technology is based on the isolation of individual immunocomplexes on paramagnetic beads using standard ELISA reagents.
We're passionate about the work we do and believe we can transform today’s sick care into tomorrow’s precision healthcare. The future of healthy living is being realized by uncovering novel biomarkers with the power to transform medicine, allowing for prevention, early diagnosis and nextgen treatments.